Shares of Crocs, Inc. (NASDAQ:CROX – Get Free Report) have earned a consensus rating of “Moderate Buy” from the eleven ratings firms that are covering the company, MarketBeat.com reports. Three research analysts have rated the stock with a hold recommendation, seven have given a buy recommendation and one has given a strong buy recommendation to the company. The average twelve-month price objective among brokers that have issued ratings on the stock in the last year is $144.64.
Several equities research analysts recently weighed in on the company. Bank of America increased their target price on Crocs from $140.00 to $150.00 and gave the company a “buy” rating in a report on Wednesday, March 20th. Wedbush reissued an “outperform” rating and issued a $154.00 target price on shares of Crocs in a report on Friday. KeyCorp lifted their target price on shares of Crocs from $130.00 to $149.00 and gave the stock an “overweight” rating in a research report on Thursday, March 21st. Barclays began coverage on shares of Crocs in a report on Monday, April 1st. They issued an “overweight” rating and a $167.00 price objective on the stock. Finally, Raymond James lifted their price objective on Crocs from $120.00 to $145.00 and gave the company a “strong-buy” rating in a research report on Friday, February 16th.
Get Our Latest Research Report on CROX
Crocs Price Performance
Crocs (NASDAQ:CROX – Get Free Report) last released its quarterly earnings results on Thursday, February 15th. The textile maker reported $2.58 EPS for the quarter, topping analysts’ consensus estimates of $2.38 by $0.20. The business had revenue of $960.10 million during the quarter, compared to analysts’ expectations of $958.39 million. Crocs had a net margin of 20.00% and a return on equity of 61.97%. The business’s quarterly revenue was up 1.6% compared to the same quarter last year. During the same quarter in the previous year, the company earned $2.65 EPS. Equities research analysts anticipate that Crocs will post 12.44 earnings per share for the current year.
Insider Activity at Crocs
In other news, Director John B. Replogle bought 1,972 shares of Crocs stock in a transaction dated Thursday, March 14th. The shares were acquired at an average price of $126.75 per share, with a total value of $249,951.00. Following the completion of the purchase, the director now owns 3,153 shares in the company, valued at approximately $399,642.75. The acquisition was disclosed in a document filed with the SEC, which is available at this hyperlink. In other Crocs news, Director John B. Replogle bought 1,972 shares of the firm’s stock in a transaction dated Thursday, March 14th. The stock was acquired at an average cost of $126.75 per share, for a total transaction of $249,951.00. Following the completion of the transaction, the director now owns 3,153 shares in the company, valued at $399,642.75. The acquisition was disclosed in a document filed with the SEC, which is available through this link. Also, Director Ian Bickley sold 16,785 shares of the firm’s stock in a transaction that occurred on Friday, February 16th. The stock was sold at an average price of $120.05, for a total transaction of $2,015,039.25. Following the transaction, the director now directly owns 31,815 shares in the company, valued at $3,819,390.75. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 39,867 shares of company stock valued at $4,786,276. 2.69% of the stock is owned by corporate insiders.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently made changes to their positions in CROX. WIT Partners Advisory Pte. Ltd. purchased a new stake in Crocs during the 4th quarter valued at about $266,431,000. Coatue Management LLC raised its position in shares of Crocs by 836.7% in the fourth quarter. Coatue Management LLC now owns 1,029,765 shares of the textile maker’s stock valued at $96,190,000 after buying an additional 919,835 shares during the last quarter. Norges Bank acquired a new position in shares of Crocs during the 4th quarter worth approximately $72,211,000. Patient Capital Management LLC purchased a new position in shares of Crocs during the 4th quarter worth $39,420,000. Finally, AQR Capital Management LLC raised its position in shares of Crocs by 141.1% during the 3rd quarter. AQR Capital Management LLC now owns 720,554 shares of the textile maker’s stock valued at $63,574,000 after buying an additional 421,712 shares during the period. 93.44% of the stock is currently owned by hedge funds and other institutional investors.
Crocs Company Profile
Crocs, Inc, together with its subsidiaries, designs, develops, manufactures, markets, distributes, and sells casual lifestyle footwear and accessories for men, women, and children under Crocs and HEYDUDE Brand in the United States and internationally. The company offers various footwear products, including clogs, sandals, slides, flips, wedges, platforms, socks, boots, charms, flip flops, sneakers, and slippers.
Read More
- Five stocks we like better than Crocs
- ESG Stocks, What Investors Should Know
- MarketBeat Week in Review – 4/29 – 5/3
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- How to Use the MarketBeat Dividend Calculator
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
Receive News & Ratings for Crocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crocs and related companies with MarketBeat.com's FREE daily email newsletter.